Telemedicine adoption in cardiology: Determinants and predictors identified using Bayesian Model Averaging and Machine Learning

心脏病学领域远程医疗应用:基于贝叶斯模型平均和机器学习的决定因素和预测因素

阅读:2

Abstract

In this secondary analysis of a German cross-sectional survey data, we investigated key determinants and predictors of telemedicine (TM) use among healthcare professionals (HCPs) treating cardiology patients. We applied Bayesian Model Averaging (BMA) for explanatory analysis and Machine Learning (ML) for predictive modeling. BMA identified TM determinants after excluding collinear variables and selecting variables based on LASSO regression. The extreme gradient boosting (XGBoost) ML algorithm predicted TM use and identified key predictors, using nested cross-validation to prevent overfitting. ML model performance was assessed via area under the receiver operating characteristic curve (AUROC), while predictor importance was evaluated using Shapley additive explanations. Among 112 HCPs, 64 (57%) used TM. BMA identified 12 determinants, including positive associations with TM knowledge, being a cardiologist, female gender, and perceiving TM as suitable for heart failure and for monitoring events. Negative associations included concerns about insufficient patient benefits, perceptions that TM is less suitable for acute events, and skepticism regarding its relevance for extending aftercare intervals. The XGBoost model showed strong predictive performance (AUROC: 0.88 [95% CI: 0.75; 1.00], accuracy: 0.79) for TM use. Key promoting factors included TM knowledge, being a cardiologist, female gender, number of average patients per quarter, and perceiving TM as suitable for arrhythmias, device follow-up, and heart failure. Limiting factors included older age, personal use of TM for one's own health, and skepticism about TM's relevance in acute situations. These findings emphasize the importance of knowledge and attitudes in shaping TM adoption and show that ML can accurately identify healthcare professionals most likely to use TM, supporting targeted interventions and safer implementation in cardiology.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。